Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Merck
QuintilesIMS
Cipla
Accenture
Johnson and Johnson
Queensland Health
Mallinckrodt
Chinese Patent Office

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 085568

« Back to Dashboard

NDA 085568 describes TRICHLORMETHIAZIDE, which is a drug marketed by Chartwell Rx, Impax Labs, Par Pharm, Sandoz, and Watson Labs, and is included in eleven NDAs. Additional details are available on the TRICHLORMETHIAZIDE profile page.

The generic ingredient in TRICHLORMETHIAZIDE is reserpine; trichlormethiazide. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine; trichlormethiazide profile page.
Summary for 085568
Tradename:TRICHLORMETHIAZIDE
Applicant:Chartwell Rx
Ingredient:trichlormethiazide
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 085568

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength4MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Moodys
Accenture
Covington
Teva
Deloitte
Queensland Health
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.